Management of delivery with FVIII/VWF concentrates in a pregnant woman with type 3 von Willebrand disease and alloantibodies

Thromb Haemost. 2012 Oct;108(4):796-8. doi: 10.1160/TH12-03-0136. Epub 2012 Jul 26.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antifibrinolytic Agents / administration & dosage
  • Blood Transfusion
  • Cesarean Section
  • Factor VIII / administration & dosage*
  • Female
  • Humans
  • Infant, Newborn
  • Isoantibodies / blood
  • Pregnancy
  • Pregnancy Complications, Hematologic / blood
  • Pregnancy Complications, Hematologic / immunology
  • Pregnancy Complications, Hematologic / therapy*
  • Tranexamic Acid / administration & dosage
  • Uterine Hemorrhage / etiology
  • Uterine Hemorrhage / therapy
  • von Willebrand Disease, Type 3 / blood
  • von Willebrand Disease, Type 3 / complications*
  • von Willebrand Disease, Type 3 / immunology
  • von Willebrand Disease, Type 3 / therapy*
  • von Willebrand Factor / administration & dosage*
  • von Willebrand Factor / immunology

Substances

  • Antifibrinolytic Agents
  • Isoantibodies
  • von Willebrand Factor
  • Tranexamic Acid
  • F8 protein, human
  • Factor VIII